A phase 2 study of docetaxel in combination with indoximod in metastatic breast cancer.

被引：4
|
作者：
Soliman, Hatem Hussein
Minton, Susan E.
Ismail-Khan, Roohi
Han, Hyo S.
Vahanlan, Nicholas N.
Ramsey, William Jay
Kennedy, Eugene
Link, Charles J.
Sullivan, Daniel
Antonia, Scott Joseph
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[2] NewLink Genet, Ames, IA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.tps3124
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS3124
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer
    P A Vasey
    H Roché
    D Bisset
    C Terret
    L Vernillet
    A Riva
    C Ramazeilles
    N Azli
    S B Kaye
    C J Twelves
    British Journal of Cancer, 2002, 87 : 1072 - 1078
  • [22] Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer
    Vasey, PA
    Roché, H
    Bisset, D
    Terret, C
    Vernillet, L
    Riva, A
    Ramazeilles, C
    Azli, N
    Kaye, SB
    Twelves, CJ
    BRITISH JOURNAL OF CANCER, 2002, 87 (10) : 1072 - 1078
  • [23] Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
    Ciardiello, F.
    Troiani, T.
    Caputo, F.
    De Laurentiis, M.
    Tortora, G.
    Palmieri, G.
    De Vita, F.
    Diadema, M. R.
    Orditura, M.
    Colantuoni, G.
    Gridelli, C.
    Catalano, G.
    De Placido, S.
    Bianco, A. R.
    BRITISH JOURNAL OF CANCER, 2006, 94 (11) : 1604 - 1609
  • [24] Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
    F Ciardiello
    T Troiani
    F Caputo
    M De Laurentiis
    G Tortora
    G Palmieri
    F De Vita
    M R Diadema
    M Orditura
    G Colantuoni
    C Gridelli
    G Catalano
    S De Placido
    A R Bianco
    British Journal of Cancer, 2006, 94 : 1604 - 1609
  • [25] Capecitabine in combination with docetaxel in the management of metastatic breast cancer
    Gennatas, C. G.
    Michalaki, V.
    Gennatas, S.
    Psychogios, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] Combination therapy with Docetaxel and mitoxantron for metastatic breast cancer
    Loibl, S
    von Minckwitz, G
    Costa, S
    Kaufmann, M
    ONKOLOGIE, 2000, 23 (03): : 5 - 6
  • [27] A phase 2 study of berzosertib (M6620) in combination with carboplatin compared with docetaxel in combination with carboplatin in metastatic castration-resistant prostate cancer.
    Choudhury, Atish Dipankar
    Xie, Wanling
    Folefac, Edmund
    Lee, Daniel
    Parikh, Mamta
    Einstein, David Johnson
    Kessler, Elizabeth R.
    Mayer, Tina M.
    McKay, Rana R.
    Pace, Amanda Fredericks
    Kochupurakkal, Bose
    Mouw, Kent William
    Van Allen, Eliezer Mendel
    Kunos, Charles
    D'Andrea, Alan D.
    Taplin, Mary-Ellen
    Shapiro, Geoffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] Extended phase I study of capecitabine in combination with vinorelbine in pretreated patients with metastatic breast cancer.
    Welt, A
    Von Minckwitz, G
    Borquez, D
    Oberhoff, C
    Kaufmann, M
    Seeber, S
    Vanhoefer, U
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S90 - S90
  • [29] Phase I study of LZM005, a HER2 antibody, as monotherapy or in combination with trastuzumab and docetaxel in patients with HER2-positive metastatic breast cancer.
    Xue, Cong
    Yao, Herui
    Lin, Ying
    An, Xin
    Chen, Meiting
    Dong, Yugang
    Li, Su
    Shi, Yanxia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [30] A phase 1/2 study of Ad.p53 DC vaccine with indoximod immunotherapy in metastatic breast cancer
    Soliman, Hatem H.
    Minton, Susan E.
    Ismail-Khan, Roohi
    Han, Hyo S.
    Vahanian, Nicholas N.
    Link, Charles J.
    Kennedy, Gene
    Streicher, Howard
    Sullivan, Daniel
    Antonia, Scott J.
    CANCER RESEARCH, 2015, 75
12345